Large-scale testing (Phase 3)Active Not RecruitingNCT05680818
What this trial is testing
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Who this might be right for
Autosomal Dominant Hypocalcemia (ADH)
Calcilytix Therapeutics, Inc., a BridgeBio company 67